ELECSYS IGE II IMMUNOASSAY
Report
- Report Number
- 1823260-2017-01123
- Event Type
- Malfunction
- Date Received
- June 1, 2017
- Date of Event
- May 10, 2017
- Report Date
- August 17, 2017
- Manufacturer
- ROCHE DIAGNOSTICS
- Product Code
- JHR
- PMA / PMN Number
- K061970
- Removal / Correction Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PO
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
SAMPLE FROM THE PATIENT WAS SUBMITTED FOR INVESTIGATION AND AN INCREASED LEVEL OF IGE-IGG COMPLEXES WAS DETECTED. THIS MOST LIKELY CAUSED THE REDUCED DETECTION OF IGE IN THE UNDILUTED SAMPLE. THESE COMPLEXES MAY RESULT FROM AN AUTO-IMMUNE DISEASE AND/OR MAY BE REMNANTS OF A TERMINATED ANTI-ALLERGY OR ANTI-ASTHMA THERAPY. PRODUCT LABELING FOR THE ASSAY STATES NOT TO USE THE ASSAY FOR PATIENTS UNDER TREATMENT WITH XOLAIR OR SIMILAR DRUGS CONTAINING ANTI-IGE ANTIBODIES.
(B)(4). THIS EVENT OCCURRED IN (B)(6).
THE CUSTOMER RECEIVED A QUESTIONABLE ELECSYS IGE II IMMUNOASSAY RESULT FOR ONE PATIENT SAMPLE. THE CUSTOMER USED COBAS 8000 E 602 MODULE SERIAL NUMBER (B)(4). THE INITIAL RESULT FOR THIS SAMPLE WAS 991.7 IU/ML. THE DOCTOR DID NOT AGREE WITH THE RESULT AS IT WAS NOT CONSISTENT WITH THE MEDICAL HISTORY. THIS PATIENT NORMALLY HAD A RESULT OF 21000 UI/ML. THE CUSTOMER PERFORMED DILUTIONS OF THE SAMPLE AS FOLLOWS: 1:5 DILUTION RESULT WAS 4569 IU/ML. A 1:10 DILUTION RESULT WAS 12609 IU/ML. A 1:50 DILUTION RESULT WAS 20333 IU/ML. A 1:100 DILUTION RESULT WAS 21548 IU/ML. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 385379 | ELECSYS IGE II IMMUNOASSAY | RADIOIMMUNOASSAY, IMMUNOGLOBULINS (D,E) | JHR | ROCHE DIAGNOSTICS | IGE | 17305400 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 19 YR |